|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets: | ||||||||||
| Cash and cash equivalents, including restricted cash (amounts related to consolidated variable interest entities of $3 million and $3 million at September 30, 2024 and December 31, 2023, respectively) | ||||||||||
| Cash and cash equivalents (amounts related to consolidated variable interest entities of $1 million and $3 million at June 30, 2026 and December 31, 2025, respectively) | ||||||||||
| Accounts receivable, net (amounts related to consolidated variable interest entities of $860 million and $876 million at June 30, 2026 and December 31, 2025, respectively) | ||||||||||
| Inventories | ||||||||||
| Other current assets | ||||||||||
| Total current assets | ||||||||||
| Property, plant and equipment, net | ||||||||||
| Goodwill | ||||||||||
| Intangibles, net | ||||||||||
| Prepaid pension asset | ||||||||||
| Other non-current assets (amounts related to consolidated variable interest entities of $394 million and $393 million at June 30, 2026 and December 31, 2025, respectively) | ||||||||||
| Total assets | ||||||||||
| Liabilities and Equity | ||||||||||
| Accounts payable | ||||||||||
| Current liabilities: | ||||||||||
| Accounts payable | ||||||||||
| Accrued expenses | ||||||||||
| Accrued compensation and benefits | ||||||||||
| Current portion of debt | ||||||||||
| Other current liabilities | ||||||||||
| Total current liabilities | ||||||||||
| Non-current debt due after one year (amounts related to consolidated variable interest entities of $366 million and $376 million at June 30, 2026 and December 31, 2025, respectively) | ||||||||||
| Deferred tax liabilities | ||||||||||
| Pension liabilities and other postretirement benefits, net of current portion | ||||||||||
| Other non-current liabilities (amounts related to consolidated variable interest entities of $336 million and $335 million at June 30, 2026 and December 31, 2025, respectively) | ||||||||||
| Total liabilities | ||||||||||
| Equity: | ||||||||||
| Preferred stock, $0.001 par value; 500,000,000 shares authorized; 10,000 shares outstanding | ||||||||||
| Common stock, $0.001 par value; 9,500,000,000 shares authorized; 524,522,908 and 522,310,486 shares outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||
| Common stock, par value one Euro | ||||||||||
| Total common stock, $0.001 par value; 9,500,000,000 shares authorized; 524,522,908 and 522,310,486 shares outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||
| Deferred shares, €1 par value; 25,000 shares authorized; Nil and 25,000 shares outstanding at December 31, 2025 and December 31, 2024, respectively | ||||||||||
| Treasury stock, at cost; 706,129 and 1,449,320 common stock at June 30, 2026, and December 31, 2025, respectively | ||||||||||
| Capital in excess of par value | ||||||||||
| Accumulated other comprehensive loss | ||||||||||
| Retained earnings | ||||||||||
| Total shareholders’ equity | ||||||||||
| Noncontrolling interests | ||||||||||
| Total equity | ||||||||||
| Total liabilities and equity |
Loading...
